Contact: Mary Ann Liebert, Mary Ann Liebert, Inc., (914) 740-2100, ext. 2121, mliebertpub@
Therapeutic Hypothermia journal announced by Mary Ann Liebert, Inc.
New Rochelle, NY- Therapeutic Hypothermia, a new online open access peer-reviewed journal, will focus on medical treatment which lowers a patient's body temperature to help reduce the risk of ischemic injury to tissues following a period of insufficient blood flow. This therapy is applicable to patients with cardiac arrrest, peripheral embolism, and ischemic stroke.
This important new journal, which will begin publication in February 2010, focuses on advancing the understanding of therapeutic hypothermia and its applications in cardiology and neurotrauma. This will be the journal of record in a field that has promising therapeutic applications. “There is a strong imperative for a dedicated multidisciplinary forum to ensure that research advances are well disseminated, and therapeutic hypothermia is well understood and used effectively to enhance patient outcomes,” says Mary Ann Liebert, president of Mary Ann Liebert, Inc.
Mary Ann Liebert, Inc. (http://www.liebertpub.com), is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Journal of Neurotrauma. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 60 journals, books, and newsmagazines is available at http://www.liebertpub.com
